Trazimera
- Product NDC
- 0069-0305
- 11-digit product format
- 000690305
- Labeler code
- 0069
- Product ID
- 0069-0305_6bb3d11b-6f9e-408c-a957-b7bacaf9e175
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- trastuzumab-qyyp
- Dosage form
- KIT
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- BLA761081
- Marketing category
- BLA
- Marketing start
- 2020-02-24
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Trazimera
- Listing expiration
- 2027-12-31
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | P188ANX8CK |
| Rxcui | 2280732, 2280737, 2472791, 2472794 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0069-0305-01 | Trazimera | 1 in 1 KIT | KIT | 1 | | 9 |
| 0069-0306-01 | Trazimera | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, POWDER, LYOPHILIZED, | 20 mL | 420 mg in 20mL | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0069-0305 | TRAZIMERA (TRASTUZUMAB-QYYP) KIT TRAZIMERA (TRASTUZUMAB-QYYP) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20241222_b9c5e894-27d2-4245-a653-df986fed3c56.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0069-0305-01 | 00069030501 | 1 KIT in 1 KIT (0069-0305-01) * 20 mL in 1 VIAL, MULTI-DOSE (0069-0306-01) * 20 mL in 1 VIAL (0069-0307-01) | 1 kit | 2020-02-24 | 0000-00-00 | No | No | Current |
| 0069-0306-01 | 00069030601 | 20 mL in 1 VIAL, MULTI-DOSE | 20 ml | | | | | Historical |